Eplontersen for Transthyretin Amyloid Cardiomyopathy.

August 28, 2026| Source: The New England journal of medicine

Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, life-threatening disease caused by deposition of misfolded transthyretin (TTR). Eplontersen, an antisense oligonucleotide, reduces the production of hepatic TTR. The effect of eplontersen on ATTR-CM is unclear. In this phase 3, international, double-blind trial, we randomly assigned, in a 1:1 ratio, patients with ATTR-CM to receive subcutaneous eplontersen (45 mg) or placebo every 4 weeks for 140 weeks, in addition to standard treatment. The primary end point was a cumulative composite of death from cardiovascular causes and recurrent cardiovascular clinical events up to week 140. The effect of death from noncardiovascular causes on the primary analysis was assessed with a cumulative composite of death from any cause and cardiovascular events up to week 140. A total of 1432 patients underwent randomization and received at least one dose of the assigned intervention (715 patients in the eplontersen group and 717 in the placebo group). The mean age of the patients was 76.4 years, and 90.6% were men. A total of 381 primary end-point events occurred in 210 patients (29.4%) receiving eplontersen, and 392 events occurred in 231 patients (32.2%) receiving placebo (rate ratio, 0.89; 95% confidence interval [CI], 0.73 to 1.09; P = 0.28). Death from cardiovascular causes, as a component of the primary end point, occurred in 74 patients in the eplontersen group and in 70 in the placebo group; there were 307 cardiovascular clinical events in the eplontersen group and 322 in the placebo group. The rate ratio for the composite of death from any cause and cardiovascular events was 0.86 (95% CI, 0.71 to 1.04). Serious adverse events occurred in 413 patients (57.8%) in the eplontersen group and in 426 (59.4%) in the placebo group. Among patients with ATTR-CM, eplontersen therapy did not lead to a lower risk of a composite of death from cardiovascular causes and recurrent cardiovascular events than placebo up to 140 weeks. (Funded by Ionis Pharmaceuticals and AstraZeneca; CARDIO-TTRansform ClinicalTrials.gov number, NCT04136171.).

Read the original source →

Extensive glacier loss in the coterminous United States.

Glaciers populate the mountain ranges of the western conterminous United States and despite their importance to alpine hydrology, their area and volume change have never been comprehensively evaluated. Our study shows that since the mid-twentieth century about one-quarter of the glaciers have disappeared and the overall area and volume are reduced by one-third. The pattern of glacier shrinkage suggests most glaciers in the conterminous United States are largely maintained by local topographic in

Physical/TechOctober 20, 2026

Reaction-based cryo-EM resolves the continuous conformational spectrum of CTP synthase catalysis.

Capturing enzymes under native turnover conditions remains a grand challenge in structural biology. Here, we develop a reaction-based cryo-electron microscopy (cryo-EM) strategy that directly samples Drosophila melanogaster cytidine triphosphate synthase (CTPS) from actively catalyzing mixtures containing only natural substrates and allosteric effectors. By integrating reaction-based sampling with three-dimensional variability analysis, we resolve a continuous conformational spectrum of CTPS dur

Physical/TechOctober 20, 2026

GTP orchestrates CTP synthase via an allosteric effector-cycling mechanism.

Cytidine triphosphate (CTP), a fundamental building block of RNA, plays vital roles in diverse biological processes. CTP synthase (CTPS) is the only known enzyme for de novo synthesis of CTP. Efficient CTPS catalysis requires guanosine triphosphate (GTP) in a dose-dependent, nonconsumptive manner; however, the precise mechanism by which GTP drives CTP formation remains unclear. Here, we integrate a series of cryo-EM structures of Drosophila melanogaster CTPS captured from actively catalyzing sam

Physical/TechOctober 20, 2026

Antiferromagnetism and tightly bound Cooper pairs induced by kinetic frustration.

Antiferromagnetism and superconductivity are often viewed as competing orders in correlated electron systems. Here, we demonstrate that kinetic frustration in hole motion facilitates their coexistence within the square-lattice repulsive Hubbard model. Combining exact analytical solutions on tailored geometries with large-scale numerical simulations, we reveal a robust pairing mechanism: Holes on opposite sublattices behave as if they carry opposite effective charges due to spin singlet formation

Physical/TechOctober 20, 2026

Coordinated transformations of the labyrinth and occiput during the dinosaur-bird transition.

Evolutionary shape changes of the vertebrate semicircular canals (SCCs) are often ascribed to evolutionary transitions in locomotion, including the origin of flight during the dinosaur-bird transition. However, the potential for transformations of braincase architecture to influence SCC shape independent of sensory-functional adaptation has generally been overlooked. We evaluate the influence of both factors using a large dataset of 146 living and recently extinct crown birds, including taxa rep